We are monitoring the impact of COVID-19 on Capecitabine Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6192
Share on
Share on

Global Capecitabine Market Size, Share, Trends, Growth Analysis Report - Segmented By Application (Colon Cancer, Rectal Cancer, Breast Cancer, Gastric Cancer and Others), Drug Formulation (Tablets and Capsules) and Region - Industry Forecast | 2019 - 2024

Pulished: February, 2020
ID: 6192
Pages: 175

Capecitabine Market Size & Growth (2019 - 2024)

The Capecitabine Market to experience moderate growth to record a CAGR of 6.2% throughout the forecast period. Capecitabine is a chemotherapy drug that works by reducing or preventing the progression of cancer cells. This medication is to treat cancers such as colorectal cancer, breast cancer, and gastric cancer. According to the American Cancer Society report, in 2017, there were predictable 135,431 new cases and 50,260 deaths from colon and rectal cancer in the US.   

The increasing demand for target drugs to decrease possible side effects without affecting healthy cells is likely to accelerate the application of the capecitabine market. The growing encumbrance for patients detected with cancer and tumours is to stimulate the market.

According to the report of the World Health Organization, cancer is one of the leading causes of death worldwide, and it is estimated that about 9.6 million deaths in 2018. Besides, Around 628,000 women have died from cancer of the breast, which accounts for about 15% of all cancer decreases in women worldwide. Also, a sharp increase in health spending continued R&D activities in cancer treatment should offer new market opportunities.

Additionally, rising awareness programs from administrations and private administrations such as Cancer Care, Cancer Research UK and Cancer Suraksha Scheme are to drive growth in the Capecitabine market during the period. 

However, the high cost of Capecitabine and strict government regulations related to the safety and efficacy of Capecitabine is hampering the growth of the global capecitabine market. 

Recent Market Developments:

In April 2019, Armas Pharmaceuticals, Inc. was delighted to publicize the launch of its second and third generic product, Imatinib and Capecitabine for the US market. These products will be the first reliable oral oncology products for Weapons. Capecitabine will be available in 150mg, and 500mg doses and Imatinib will be available in 100mg and 400mg doses.

In July 2017, Headquartered at Hikma Pharmaceuticals has launched 150mg and 500mg tablets of Capecitabine, the generic equivalents of Xeloda, through its affiliate West-Ward Pharmaceuticals. West-Ward Capecitabine tablets are indicated for adjuvant therapy in patients with colon cancer C, as monotherapy for metastatic colorectal cancer.

In August 2014, Mylan Inc. (Nasdaq: MYL) announced the release of Capecitabine Tablets USP, 150mg and 500mg, the generic version of Genentech Xeloda® tablets. Mylan received final approval from the United States Food and Drug Administration (FDA) for its Short Drug Application (ANDA) for this product. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018-2024

Base Year

2018

Forecast Period

2019-2024

Segments Covered

By Application, Drug Formulation and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the Global Capecitabine Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

Capecitabine Market Analysis – By Application

  • Colon Cancer          
  • Rectal Cancer         
  • Breast Cancer        
  • Gastric Cancer       
  • Others      

Capecitabine Market Analysis – By Drug Formulation

  • Tablets      
  • Capsules  

Regional Analysis:

North America accounted for the largest share of the Capecitabine market, followed by Europe and the Asia Pacific. Asia Pacific is to witness the highest CAGR in the coming years.

Companies dominating the Global Capecitabine market profiled in this report are:

  • Novartis AG
  • Sensus Healthcare
  • RXi Pharmaceuticals, Inc.
  • Sonoma Pharmaceuticals, Inc.
  • Perrigo Company plc
  • Bristol-Myers Squibb Company
  • Pacific World Corporation
  • Valeant Pharmaceuticals International, Inc.
  • Revitol Corporation
  • Avita Medical Limited

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Colon Cancer          

                                5.1.3 Rectal Cancer         

                                5.1.4 Breast Cancer        

                                5.1.5 Gastric Cancer       

                                5.1.6 Others      

                                5.1.7 Y-o-Y Growth Analysis, By Application         

                                5.1.8 Market Attractiveness Analysis, By Application       

                                5.1.9 Market Share Analysis, By Application        

                5.2 Drug Formulation                     

                                5.2.1 Introduction           

                                5.2.2 Tablets      

                                5.2.3 Capsules  

                                5.2.4 Y-o-Y Growth Analysis, By Drug Formulation            

                                5.2.5 Market Attractiveness Analysis, By Drug Formulation          

                                5.2.6 Market Share Analysis, By Drug Formulation            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Drug Formulation

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Drug Formulation

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Drug Formulation

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Novartis AG                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Sensus Healthcare                   

                8.3 RXi Pharmaceuticals Inc.                       

                8.4 Sonoma Pharmaceuticals Inc.                             

                8.5 Perrigo Company plc                              

                8.6 Bristol-Myers Squibb Company                         

                8.7 Pacific World Corporation                     

                8.8 Valeant Pharmaceuticals International Inc.                   

                8.9 Revitol Corporation                 

                8.10 Avita Medical Limited.                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Global Capecitabine  Market By Region, From 2019-2024 ( USD Million )
  2. Global Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  3. Global Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  4. Global Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  5. Global Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  6. Global Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  7. Global Others Market By Region, From 2019-2024 ( USD Million )
  8. Global Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  9. Global Tablets Market By Region, From 2019-2024 ( USD Million )
  10. Global Capsules Market By Region, From 2019-2024 ( USD Million )
  11. North America Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  12. North America Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  13. North America Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  14. North America Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  15. North America Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  16. North America Others Market By Region, From 2019-2024 ( USD Million )
  17. North America Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  18. North America Tablets Market By Region, From 2019-2024 ( USD Million )
  19. North America Capsules Market By Region, From 2019-2024 ( USD Million )
  20. United States Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  21. United States Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  22. Canada Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  23. Canada Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  24. Europe Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  25. Europe Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  26. Europe Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  27. Europe Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  28. Europe Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  29. Europe Others Market By Region, From 2019-2024 ( USD Million )
  30. Europe Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  31. Europe Tablets Market By Region, From 2019-2024 ( USD Million )
  32. Europe Capsules Market By Region, From 2019-2024 ( USD Million )
  33. U.K. Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  34. U.K. Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  35. Germany Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  36. Germany Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  37. France Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  38. France Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  39. Italy Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  40. Italy Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  41. Spain Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  42. Spain Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  43. Asia Pacific Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  44. Asia Pacific Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  45. Asia Pacific Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  46. Asia Pacific Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  47. Asia Pacific Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  48. Asia Pacific Others Market By Region, From 2019-2024 ( USD Million )
  49. Asia Pacific Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  50. Asia Pacific Tablets Market By Region, From 2019-2024 ( USD Million )
  51. Asia Pacific Capsules Market By Region, From 2019-2024 ( USD Million )
  52. Japan Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  53. Japan Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  54. China Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  55. China Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  56. India Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  57. India Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  58. Australia Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  59. Australia Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  60. South Korea Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  61. South Korea Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  62. Latin America Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  63. Latin America Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  64. Latin America Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  65. Latin America Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  66. Latin America Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  67. Latin America Others Market By Region, From 2019-2024 ( USD Million )
  68. Latin America Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  69. Latin America Tablets Market By Region, From 2019-2024 ( USD Million )
  70. Latin America Capsules Market By Region, From 2019-2024 ( USD Million )
  71. Brazil Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  72. Brazil Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  73. Argentina Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  74. Argentina Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  75. Mexico Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  76. Mexico Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  77. Rest of Latin America Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  78. Rest of Latin America Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  79. Middle East and Africa Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  80. Middle East and Africa Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  81. Middle East and Africa Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  82. Middle East and Africa Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  83. Middle East and Africa Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  84. Middle East and Africa Others Market By Region, From 2019-2024 ( USD Million )
  85. Middle East and Africa Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  86. Middle East and Africa Tablets Market By Region, From 2019-2024 ( USD Million )
  87. Middle East and Africa Capsules Market By Region, From 2019-2024 ( USD Million )
  88. Middle East Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  89. Middle East Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  90. Africa Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  91. Africa Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample